Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion type Assertion NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_head.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion description "[We investigated the effect of bezafibrate, a peroxisome proliferator-activated receptor ? agonist, on circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_provenance.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion evidence source_evidence_literature NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_provenance.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion SIO_000772 25134759 NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_provenance.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion wasDerivedFrom befree-2016 NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_provenance.
- NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_assertion wasGeneratedBy ECO_0000203 NP1211719.RAEtX4beIygoAADZ14ICYdcT1K7vaPe4_vV6XWfBVcnz4130_provenance.